This accredited learning module explores how to initiate injectable therapy in a patient with type 2 diabetes who remains above their glycaemic target despite taking dual or triple oral therapy. The activity works through 3 in-depth case-studies: a patient with uncomplicated T2D, a patient with ASCVD risk, and a patient with established ASCVD.
Dr Tom Dover (Endocrinologist, Queensland Health) and Dr Ashraf Saleh (GP, Toowomba, Qld) discuss the role of injectable therapies in the ongoing management of type 2 diabetes, and outline methods to reduce barriers and improve patient outcomes.
Gonzalo Jacome, Senior Staff Clinician, Centre for Eye Health, UNSW discusses how general practitioners can provide effective first-line care for a range of eye conditions. Ways to diagnose eye conditions in a telehealth consultation are explored, as well as the identification of ocular emergencies and coordinating care with optometrists in glaucoma management.
Select the best management options for a type 2 diabetes patient on insulin therapy in this case study quiz.
Recently published consensus statement: Practical guidance for the use of IDegAsp in type 2 diabetes
Dr Sarah Glastras provides practical advice on the usage of the insulin degludec/insulin aspart coformulation, and outlines its role in insulin initiation and intensification in light of the recently released consensus statement.
Decide on the best course of action for a patient at risk of diabetes-related retinopathy in this case study quiz.
This guide summarises key information about DR in patients with type 2 diabetes and the GP’s role in screening, management and referral.
Dr Michelle Kiley outlines the aetiology and classification of status epilepticus, a condition involving abnormally prolonged seizues, and provides guidance on its identification, possible complications and management.